March 2026 brought a more concentrated set of UK-linked M&A stories than February, but the strategic logic was sharper. The month’s most consequential announcements were not broad bets on a fully reopened market. They were targeted moves into assets and businesses where scale, specialism, regulated cashflows, or cross-border reach still justified bold capital commitments.
The backdrop remained uneven. The Bank of England held Bank Rate at 3.75% in March, said activity had remained subdued in the first quarter, and noted that monthly GDP was flat in January as higher energy prices darkened the near-term inflation picture. At the same time, the Office for National Statistics had just reported that inward UK M&A value rose to £27.4 billion in Q4 2025, the highest since Q2 2021, even as domestic M&A value fell to £1.8 billion, the lowest since Q2 2020.
That combination — subdued domestic conditions, but continued appetite for large and strategic transactions — shaped March’s deal flow. PwC has argued that UK M&A entered 2026 with fewer deals but bigger ticket sizes, and Herbert Smith Freehills Kramer said March produced three Rule 2.7 announcements and seven further possible offers or sale processes in the UK public M&A market.
Selective conviction, not broad exuberance —
The clearest statement of intent came from Unilever. On 31 March, the company said it would combine its foods business with McCormick in a transaction that would create a group worth around $65 billion. Unilever said the deal implied an enterprise value of about $44.8 billion for its foods unit, would deliver $15.7 billion in cash to Unilever, and would leave Unilever and its shareholders with 65% of the fully diluted combined company equity. Fernando Fernandez described it as “another decisive step in sharpening our portfolio”.
This was the month’s defining UK-linked deal because it was larger than a portfolio tidy-up. It signalled that one of Britain’s biggest listed companies was willing to accelerate a structural shift towards higher-growth personal care, wellbeing, and home care, while using a deal structure that still preserved upside. For the wider market, the transaction reinforced a broader March theme: the most valuable deals were the ones that materially changed strategic direction, rather than merely adding adjacent revenue.
Insurance produced March’s other standout public-market move. Zurich agreed to acquire Beazley for £8.1 billion, with Beazley shareholders set to receive 1,335 pence per share. The transaction would significantly expand Zurich’s reach in cyber, marine, aviation, space, and fine art insurance. Mario Greco, Zurich’s chief executive, said the two companies would create “the world’s leading Specialty underwriter”.
The importance of the Beazley deal ran beyond the headline number. Specialty insurance has been one of the market’s more attractive corners because pricing discipline, niche expertise, and data-led underwriting still matter. March showed that this combination of defensible capability and international distribution remained attractive enough to support a large, cross-border bid for a UK company, even in a choppy macro environment. The takeover may also pave the way for further sector consolidation.
Rosebank Industries offered a different kind of signal. On 3 March, the British investor said it would buy U.S.-based MW Components and CPM for $3.05 billion, in what it described as the next major step in its “buy, improve, sell” strategy. The acquisition was set to be funded through a £1.9 billion equity raise and new debt, and it marked Rosebank’s biggest deal since its 2025 purchase of Electrical Components International.
For UK deal watchers, that mattered because it showed London capital still being used to back industrial scale-building abroad. The story was not defensive. It was expansionary, and disciplined. At a point when many boards were still weighing macro risks, Rosebank moved decisively on manufacturing assets where operational improvement and future exit value were central to the thesis. That is a useful reminder that in 2026, selective appetite is still appetite.
EQT’s move on Kelda Holdings, the parent company of Yorkshire Water, was smaller in disclosed detail, but arguably larger in signal value. On 9 March, EQT agreed to buy a 42% stake in Kelda, one of the sector’s largest recent investments, and would also help repay an approximately £600 million loan due before March 2027. Yorkshire Water said the agreement signalled confidence in the company’s plans, while the company’s debt position kept the wider balance-sheet story in focus.
This was one of March’s most consequential UK M&A stories because it landed in a sector defined by political scrutiny, debt pressure, and infrastructure need. EQT’s Kunal Koya called water “a critical resource”. In editorial terms, the point is wider than Yorkshire Water. Capital is still willing to back essential UK infrastructure where there is a plausible path to operational improvement, financial stabilisation, and long-duration relevance.
Savills rounded out the month’s top five with a transatlantic capability deal. On 12 March, the UK property adviser said it would acquire Eastdil Secured for $1.1 billion, including debt. Eastdil generates 76% of its revenue from North America, and Savills expects the transaction to generate direct revenue synergies of at least £60 million annually over the medium term.
The strategic case was straightforward. Savills was not buying volume for its own sake. It was buying deeper exposure to U.S. capital markets, restructuring, debt placement, and real estate advisory at a point when stronger pipelines were beginning to re-emerge. In a month shaped heavily by inbound interest in UK assets, Savills offered the counterpoint: a British company using M&A to strengthen overseas reach and move earlier than a full market recovery.
What March’s deal mix says about the UK —
March was, above all, a cross-border month. Four of the five defining transactions were explicitly international, and even the Yorkshire Water investment sat squarely inside a broader debate about overseas capital, regulated assets, and UK infrastructure resilience. First-quarter global M&A topped $1.2 trillion, cross-border activity rose 47% year on year to $454.7 billion, and the UK was the second-most targeted nation in cross-border transactions after the United States. As Barclays’ Andrew Woeber put it: “CEOs and boards aren’t waiting for perfect conditions.”
The second pattern was strategic sharpening. Unilever used M&A to simplify its portfolio. Zurich bought specialist capability. Rosebank scaled an industrial platform. Savills expanded into higher-value advisory terrain. EQT backed essential infrastructure with a balance-sheet element at the centre of the story. Taken together, those moves suggest that March’s UK M&A stories were less about cyclical optimism and more about deliberate repositioning.
Four takeaways for business leaders —
- Decide what makes your asset strategically necessary. The strongest bids in March were attached to businesses that offered something difficult to replicate — category leadership, specialist underwriting, essential infrastructure, or geographic reach. In this market, generic growth stories look less persuasive than durable strategic relevance.
- Treat cross-border optionality as a strength, not an accessory. March’s top stories showed UK companies and UK targets still sitting inside global capital flows. Boards that understand where overseas buyers, partners, or investors may see value are likely to be better prepared, whether they are defending independence or pursuing expansion.
- Financing structure is now part of the strategy. The most important deals were not just about valuation. They were also about how cash, equity, debt, and future ownership were being used to make a strategic shift workable. That was especially clear in Unilever’s deal structure, Rosebank’s funding plan, and EQT’s role in supporting Kelda’s balance sheet.
- Preparation still separates the credible from the hopeful. Boards that have a sharper thesis, cleaner diligence, and a clearer financing plan are better placed to transact in a market that still rewards conviction, but not carelessness.
March did not signal a fully reopened UK M&A market. It did, however, show exactly where buyers are still willing to move: into scale, scarce capability, regulated assets, and businesses that help reshape a portfolio rather than simply enlarge it. The month also left live situations as reminders that process activity remained active beyond the biggest completed or recommended transactions.
You must be logged in to post a comment.